LL1612-2
PhenX14_34_assay exclusion criteria, serum insulin
Active
Basic Properties
- OID
- 1.3.6.1.4.1.12009.10.1.783
- Name
- PhenX14_34_assay exclusion criteria, serum insulin
- Description
- Taking insulin/Hemophilia/Received cancer chemotherapy in the last 3 weeks/Has not fasted at least 9 hours/None - proceed with blood draw
- LOINCs using this list
- 1
Answer List
Answer | Code | Score | Answer ID |
---|---|---|---|
Taking insulin | LA15172-2 | ||
Hemophilia | LA15174-8 | ||
Received cancer chemotherapy in the last 3 weeks | LA15175-5 | ||
Has not fasted at least 9 hours | LA15176-3 | ||
None – proceed with blood draw | LA15177-1 |
LOINC terms using this Answer List
66505-9 | Exclusion criteria for fasting serum insulin [PhenX] |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LL1612-2 - ValueSet definition
- https:
//fhir.loinc.org/ValueSet/?url=http: //loinc.org/vs/LL1612-2 - ValueSet expansion
- https:
//fhir.loinc.org/ValueSet/$expand?url=http: //loinc.org/vs/LL1612-2
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright